We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.44B
AUM Growth
+$71.4M
Cap. Flow
-$5.26M
Cap. Flow %
-0.22%
Top 10 Hldgs %
47.84%
Holding
319
New
22
Increased
148
Reduced
94
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 12.77%
2 Healthcare 7.71%
3 Financials 5.22%
4 Industrials 4.55%
5 Communication Services 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
76
Lockheed Martin
LMT
$134B
$7.38M 0.3%
15,606
+1,181
+8% +$554K
SBUX icon
77
Starbucks
SBUX
$120B
$7.31M 0.3%
70,202
+16,823
+32% +$1.75M
XOM icon
78
ExxonMobil
XOM
$644B
$7.26M 0.3%
66,209
+3,324
+5% +$368K
GOOG icon
79
Alphabet (Google) Class C
GOOG
$4.36T
$7.26M 0.3%
69,803
+280
+0.4% +$27K
HPE icon
80
Hewlett Packard
HPE
$63.4B
$6.28M 0.26%
+394,257
New +$6.19M
IWM icon
81
iShares Russell 2000 ETF
IWM
$79.8B
$6.03M 0.25%
33,790
-527
-2% -$97K
HSY icon
82
Hershey
HSY
$35.2B
$5.94M 0.24%
23,350
-1,696
-7% -$398K
SCHX icon
83
Schwab US Large- Cap ETF
SCHX
$71.8B
$5.78M 0.24%
358,680
-2,976
-0.8% -$46.8K
ABT icon
84
Abbott
ABT
$183B
$5.51M 0.23%
54,460
+20
+0% +$2.11K
PEP icon
85
PepsiCo
PEP
$190B
$5.4M 0.22%
29,620
+1,871
+7% +$327K
VEA icon
86
Vanguard FTSE Developed Markets ETF
VEA
$229B
$5.1M 0.21%
112,978
+21,409
+23% +$954K
MET icon
87
MetLife
MET
$61.9B
$5.08M 0.21%
87,600
+8,015
+10% +$541K
SCHF icon
88
Schwab International Equity ETF
SCHF
$66.6B
$4.89M 0.2%
281,280
+1,326
+0.5% +$22.7K
SPEM icon
89
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$4.77M 0.2%
139,638
-136
-0.1% -$4.68K
BRK.B icon
90
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.75M 0.19%
15,385
-80
-0.5% -$24.7K
PG icon
91
Procter & Gamble
PG
$336B
$4.3M 0.18%
28,933
+1,604
+6% +$229K
JHMM icon
92
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$4.23M 0.17%
88,301
-383
-0.4% -$18.6K
FNF icon
93
Fidelity National Financial
FNF
$13.9B
$4.21M 0.17%
120,567
+12,322
+11% +$485K
PFE icon
94
Pfizer
PFE
$143B
$3.66M 0.15%
89,679
+8,113
+10% +$350K
VOO icon
95
Vanguard S&P 500 ETF
VOO
$979B
$3.39M 0.14%
9,026
+376
+4% +$138K
MCD icon
96
McDonald's
MCD
$192B
$3.39M 0.14%
12,121
+15
+0.1% +$4.02K
SPSM icon
97
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$3.34M 0.14%
88,490
-2,527
-3% -$98.7K
VBK icon
98
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$3.21M 0.13%
14,816
+32
+0.2% +$6.92K
VWO icon
99
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.05M 0.12%
75,394
+8,755
+13% +$357K
IEO icon
100
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
$3.03M 0.12%
35,343
-269
-0.8% -$24.1K

Similar funds

Grimes & Company's Q1 2023 Portfolio in Review

As of Q1 2023, Grimes & Company held 319 positions worth $2.44B, up 3% from $2.37B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company's Q1 2023 filing shows 22 new, 148 increased, 94 reduced and 14 closed positions. Its largest new stake was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2023 buy was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2023, an estimated $225M increase.
  • Grimes & Company's biggest Q1 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $349M.
  • Grimes & Company fully exited SVB Financial Group in Q1 2023, selling an estimated $5.35M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.44B portfolio in Q1 2023.
  • Grimes & Company opened 22 new positions and closed 14 in Q1 2023.
  • Grimes & Company's portfolio value rose 3% quarter-over-quarter to $2.44B.

Based on Grimes & Company's 13F filing for Q1 2023, filed 20 Apr 2023.